Table I. Quantification of Nuclear Staining Intensity following Overexpression or Knockdown of EZH2.
Endogenous* | Expression** | Nuclear Staining** | |||||
---|---|---|---|---|---|---|---|
EZH2 | EED | Ratio† | EZH2 | shEZH2 | EZH2 ± SD | shEZH2 ± SD | |
LAPC4 | 0.060 | 0.101 | 0.6 | 11.0 | 0.3 | 1.52 ± 0.35 | 0.53 ± 0.02 |
LNCaP | 0.032 | 0.027 | 1.2 | 4.3 | 0.5 | 1.8 ± 0.04 | 0.45 ± 0.01 |
22Rv1 | 0.066 | 0.036 | 1.8 | 7.0 | 0.4 | 1.46 ± 0.14 | 0.31 ± 0.03 |
PC3 | 0.038 | 0.018 | 2.1 | 9.0 | 0.3 | 1.35 ± 0.20 | 0.51 ± 0.15 |
DU145 | 0.026 | 0.047 | 0.6 | 5.6 | 0.8 | 1.86 ± 0.04 | 0.69 ± 0.13 |
EZH2: Overexpression of EZH2, shEZH2: Knockdown of EZH2.
Relative to β-Actin;
Nuclear staining for H3K27Me3 was quantified in at least two GFP positive cells in each field, quantities shown are fold change over respective controls;
Ratio of EZH2 to EED.